期刊
JOURNAL OF PHARMACY AND PHARMACOLOGY
卷 65, 期 7, 页码 970-979出版社
WILEY-BLACKWELL
DOI: 10.1111/jphp.12061
关键词
basolateral peptide transporter; drug delivery; intestinal epithelium; proton-coupled peptide transporter
资金
- Predicting Drug Absorption Consortium (The Danish Strategic Research Council)
- Carlsberg Foundation [2009-01-0635]
Objectives Transepithelial di/tripeptide transport in enterocytes occurs via the apical proton-coupled peptide transporter, hPEPT1 (SLC15A1) and a basolateral peptide transporter, which has only been characterized functionally. In this study we examined the pH dependency, substrate uptake kinetics and substrate specificity of the transporter. Methods We studied the uptake of [14C]Gly-Sar from basolateral solution into Caco-2 cell monolayers grown for 17-22 days on permeable supports, at a range of basolateral pH values. Key findings Basolateral Gly-Sar uptake was pH dependent, with a maximal uptake rate at a basolateral pH of 5.5. Uptake of Gly-Sar decreased in the presence of the protonophore nigericin, indicating that the uptake was proton-coupled. The uptake was saturable, with a maximal flux (Vmax) of 408 +/- 71, 307 +/- 25 and 188 +/- 19pmol/cm2/min (mean +/- S.E., n=3) at basolateral pH5.0, 6.0 and 7.4, respectively. The compounds Gly-Asp, Glu-Phe-Tyr, Gly-Glu-Gly, Gly-Phe-Gly, lidocaine and, to a smaller degree, para-aminohippuric acid were all shown to inhibit the basolateral uptake of Gly-Sar. Conclusions The study showed that basolateral Gly-Sar transport in the intestinal cell line Caco-2 is proton-coupled. The inhibitor profile indicated that the transporter has broad substrate specificity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据